TANG Capital Partners L.P., 10% Owner, Director at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 920,786 shares at $5.33 ($4.9M) on 2019-01-08, disclosed to the SEC on 2019-01-09.
Open-market purchase of $4.9M LJPC by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.24 | 200,000 | $1.0M | 21.3% |
| 2 | $5.33 | 200,000 | $1.1M | 21.7% |
| 3 | $5.34 | 200,000 | $1.1M | 21.7% |
| 4 | $5.38 | 200,000 | $1.1M | 21.9% |
| 5 | $5.43 | 120,786 | $656K | 13.3% |
| Total | $5.34 avg | 920,786 |
| $4.9M |
| 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |